Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $588.00 price target on HCA Healthcare Inc (NYSE: HCA).

The analyst commented. "Positively trending DPP survey results (70% view '26 > 25 vs. 56% in prior survey) are most positive for HCA, as it has the largest Y/Y headwind to over-step at $250-400M. On core metrics, survey results are not as strong as inpatient consensus expectations for HCA (1.1% vs. 2.2%, respectively), but achievable on outpatient."

For an analyst ratings summary and ratings history on HCA Healthcare Inc click here. For more ratings news on HCA Healthcare Inc click here.

Shares of HCA Healthcare Inc closed at $474.75 yesterday.